Jenburkt Pharma Live Share Price Today, Share Analysis and Chart

Name: Jenburkt Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Jenburkt Pharmaceuticals Ltd.
Rating: 2.276583375
Author: Trendlyne DVM scores

Mid-range Performer

Iran war impact

Based on the latest financial disclosures and annual reports (up to March 2026), the impact of the Middle East conflict on Jenburkt Pharmaceuticals Ltd. is minimal. The company maintains a predominantly domestic focus with very limited direct...

1012.95 5.40 (0.54%)

28.16% Fall from 52W High

177

BSE Volume

BSE 02 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

40.0 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

No estimates available

Jenburkt Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Jenburkt Pharmaceuticals Ltd. worth buying?

29 Votes:

Buy 65.52%

Sell 20.69%

Hold 13.79%

Jenburkt Pharma Live Share Price Today, Share Analysis and Chart

Based on the latest financial disclosures and annual reports (up to March 2026), the impact of the Middle East conflict on Jenburkt Pharmaceuticals Ltd. is minimal. The company maintains a predominantly domestic focus with very limited direct...

28.16% Fall from 52W High

SWOT Analysis

Jenburkt Pharma Live Price Chart